Eugenie S. Kleinerman

11.1k citations

212 papers · 7.9k indexed · 2 hit papers · h-index 51

Immunology top 1%
- Immunotherapy and Immune Responses 26
- Immune Cell Function and Interaction 17
Oncology top 0.5%
- CAR-T cell therapy research 17
Cancer Research top 1%
Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment 52
Molecular Biology top 2%
- RNA Interference and Gene Delivery 33
- Angiogenesis and VEGF in Cancer 20
- Cell death mechanisms and regulation 13
Genetics
- Virus-based gene therapy research 21

Co-authors: Zhichao Zhou Isaiah J. Fidler Shu-Fang Jia Laura L. Worth Nancy Gordon Nadezhda V. Koshkina Brock A. Lindsey Justin Markel
Cited by: Immunology Oncology Cancer Research
Journals: Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)
Partner nations: United States Japan Australia

In The Last Decade

Eugenie S. Kleinerman

212 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Eugenie S. Kleinerman

Since Specialization

Citations

This map shows the geographic impact of Eugenie S. Kleinerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenie S. Kleinerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenie S. Kleinerman more than expected).

Fields of papers citing papers by Eugenie S. Kleinerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenie S. Kleinerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenie S. Kleinerman. The network helps show where Eugenie S. Kleinerman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eugenie S. Kleinerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eugenie S. Kleinerman Line = papers co-authored together Eugenie S. Kleinerman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CD103+ cDC1 Dendritic Cell Vaccine Therapy for Osteosarcoma Lung Metastases Cancers ·Yuanzheng Yang,Yifan Zhou,Jian Wang,You Zhou,Stephanie S. Watowich,Eugenie S. Kleinerman	2024	4
2	Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention Clinical Cancer Research ·Prince Jeyabal,Anchit Bhagat,Fei Wang,Michael Roth,J. Andrew Livingston,Susan C. Gilchrist,José Banchs,Michelle A.T. Hildebrandt,Joya Chandra,Anita Deswal,Efstratios Koutroumpakis,Jian Wang,Najat C. Daw,Theresa A. Honey,Eugenie S. Kleinerman	2023	6
3	Cigarette smoke exposure accelerates AML progression in FLT3-ITD models Blood Advances ·Mary Figueroa,Huaxian Ma,Mansour Alfayez,Daniel E. Morales-Mantilla,Fei Wang,Yue Lu,Marcos R. Estecio,Katherine Y. King,Eugenie S. Kleinerman,Seyed Javad Moghaddam,Naval Daver,Michael Andreeff,Marina Konopleva,Courtney D. DiNardo,Joya Chandra	2023	2
4	Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103⁺ conventional dendritic cells Journal for ImmunoTherapy of Cancer ·Yifan Zhou,Natalie Slone,Taylor T. Chrisikos,Oleksandr Kyrysyuk,Rachel L. Babcock,Yusra B. Medik,Haiyan S. Li,Eugenie S. Kleinerman,Stephanie S. Watowich	2020	84
5	Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial Clinical Cancer Research ·Vivek Subbiah,Pete Anderson,Kalevi Kairemo,Kenneth R. Hess,Winston W. Huh,Vinod Ravi,Najat C. Daw,Neeta Somaiah,Joseph A. Ludwig,Robert S. Benjamin,Sant P. Chawla,David S. Hong,Funda Meric‐Bernstam,Gregory Ravizzini,Eugenie S. Kleinerman,Homer A. Macapinlac,Eric Rohren	2019	32
6	Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients Molecular Cancer Therapeutics ·J. Andrew Livingston,Wei‐Lien Wang,Jen-Wei Tsai,Alexander J. Lazar,Cheuk Hong Leung,Heather Lin,Shailesh Advani,Najat C. Daw,Janice M. Santiago‐O’Farrill,Mario Hollomon,Nancy Gordon,Eugenie S. Kleinerman	2018	15
7	Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases Cancer Immunology Research ·Jiemiao Hu,Chantale Bernatchez,Liangfang Zhang,Xueqing Xia,Eugenie S. Kleinerman,Mien‐Chie Hung,Patrick Hwu,Shulin Li	2017	21
8	miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases Molecular Cancer Therapeutics ·Yuanzheng Yang,Gangxiong Huang,Zhichao Zhou,Jason G. Fewell,Eugenie S. Kleinerman	2017	12
9	Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo Clinical Cancer Research ·Denada Dibra,Abhisek Mitra,Melisa Newman,Xueqing Xia,Jeffry J. Cutrera,Mihai Gagea,Eugenie S. Kleinerman,Guillermina Lozano,Shulin Li	2016	12
10	Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells Cancer Research ·Arun Satelli,Abhisek Mitra,Jeffry J. Cutrera,Marcos Devarie,Xueqing Xia,Davis R. Ingram,Denada Dibra,Neeta Somaiah,Keila E. Torres,Vinod Ravi,Joseph A. Ludwig,Eugenie S. Kleinerman,Shulin Li	2014	131
11	EWS‐FLI‐1 regulates the neuronal repressor gene REST, which controls Ewing sarcoma growth and vascular morphology Cancer ·Zhichao Zhou,Ling Yu,Eugenie S. Kleinerman	2014	18
12	Blocking SDF-1α/CXCR4 Downregulates PDGF-B and Inhibits Bone Marrow–Derived Pericyte Differentiation and Tumor Vascular Expansion in Ewing Tumors Molecular Cancer Therapeutics ·Randala Hamdan,Zhichao Zhou,Eugenie S. Kleinerman	2013	32
13	SDF-1α Induces PDGF-B Expression and the Differentiation of Bone Marrow Cells into Pericytes Molecular Cancer Research ·Randala Hamdan,Zhichao Zhou,Eugenie S. Kleinerman	2011	28
14	Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Groupbreakdown → Journal of Clinical Oncology ·Paul A. Meyers,Cindy L. Schwartz,Mark Krailo,John H. Healey,Mark L. Bernstein,Donna L. Betcher,William S. Ferguson,Mark C. Gebhardt,Allen M. Goorin,Michael B. Harris,Eugenie S. Kleinerman,Michael P. Link,Helen Nadel,Michael L. Nieder,Gene P. Siegal,Michael A. Weiner,Robert J. Wells,Richard B. Womer,Holcombe E. Grier	2008	520
15	EWS/FLI1 Regulates Tumor Angiogenesis in Ewing's Sarcoma via Suppression of Thrombospondins Cancer Research ·Gary Potikyan,Rupert O.V. Savene,Julie M. Gaulden,Kelly A. France,Zhichao Zhou,Eugenie S. Kleinerman,Stephen L. Lessnick,Christopher T. Denny	2007	32
16	Adenovirus-mediated human topoisomerase IIα gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells Acta Oncologica ·Takeshi Asano,Eugenie S. Kleinerman,Leonard A. Zwelling,Zhichao Zhou,Yoshitaka Fukunaga	2005	11
17	E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs. PubMed ·Zhichao Zhou,Shu Jia,Mien‐Chie Hung,Eugenie S. Kleinerman	2001	50
18	9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. PubMed ·Nadezhda V. Koshkina,Eugenie S. Kleinerman,C Waidrep,Shu‐Fang Jia,Laura L. Worth,Brian E. Gilbert,Vernon Knight	2000	85
19	Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. PubMed ·Eugenie S. Kleinerman,Rebecca D. Knowles,Lawrence B. Lachman,J. U. Gutterman	1988	37
20	Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Eugenie S. Kleinerman,Charles A. Daniels,Yue Li,Ralph Snyderman	1976	45

About Eugenie S. Kleinerman

Eugenie S. Kleinerman is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 212 papers that have together received 7.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (52 papers), RNA Interference and Gene Delivery (33 papers), Immunotherapy and Immune Responses (26 papers), Virus-based gene therapy research (21 papers), Angiogenesis and VEGF in Cancer (20 papers), Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (17 papers) and Cell death mechanisms and regulation (13 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (2.8k citations) and Cancer Research (1.3k citations). Eugenie S. Kleinerman has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Zhichao Zhou, Isaiah J. Fidler, Shu-Fang Jia, Laura L. Worth, Nancy Gordon, Nadezhda V. Koshkina, Brock A. Lindsey, Justin Markel, Hui Guan and Xiaoping Duan. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact